We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Technology Differentiates Five Entamoeba Species

By LabMedica International staff writers
Posted on 06 Jun 2013
Print article
A rapid, high-throughput screening method has been developed for the simultaneous detection and differentiation of Entamoeba species.

Among the Entamoeba species, only E. histolytica is considered to be pathogenic, causing intestinal and extraintestinal disease, but it is morphologically identical to E. dispar and E. moshkovskii.

Scientists at The Federal University of Rio de Janeiro (Brazil) extracted 74 DNA samples from human stools and nine of these DNA extracts were from stools that were positive for Entamoeba species by microscopy. Polymerase chain reaction (PCR) amplification was performed with biotinylated Entamoeba spp 18S ribosomal ribonucleic acid (rRNA) gene primers, designed to amplify a fragment ranging from 382 to 429 base pairs (bp) of the Entamoeba species studied.

All parasitological positive samples were tested using real-time PCR and nine stools samples were also analyzed by DNA sequencing. In addition regions of the fragments that could differentiate among E. histolytica, E. moshkovskii, E. dispar, E. hartmanii and E. coli were selected to design hybridization probes to link to Luminex beads (Austin, TX, USA). The assay was standardized with cloned DNA samples of each species and evaluated with 24 DNA extracts from samples obtained from individuals diagnosed with these amebae in their stools.

The investigators were able to correctly identify the five different species in all of the specimens studied. From the 24 samples tested by microscopy, PCR/DNA Sequencing and real-time PCR, there was 100% concordance with the PCR-Luminex assay for identification of E. dispar, E. moshkovskii, E. hartmanni, E. histolytica, and E. coli. They were able to identify samples with more than one species of Entamoeba by performing a Luminex assay and all fifty parasitologically negative stool samples were negative in the assay.

The authors concluded that that the method could be used in the diagnostic detection of Entamoeba species in fecal samples. This diagnostic test was useful to clearly distinguish the pathogenic E. histolytica from the other species and also to strengthen epidemiologic data on Entamoeba species. The study was published on March 15, 2013, in the journal Parasites & Vectors.

Related Links:

The Federal University of Rio de Janeiro

Luminex

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.